Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

HSK 40118

Next Previous
X
Search
Drug Profile

HSK 40118

Alternative Names: HSK-40118

Latest Information Update: 06 Oct 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Haisco Pharmaceutical Group
  • Class Antineoplastics; Small molecules
  • Mechanism of Action ErbB receptor degraders
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Phase I Non-small cell lung cancer

Most Recent Events

  • 04 Oct 2023 HSK 40118 is available for licensing as of 04 Oct 2023. https://en.haisco.com/Cooperator/
  • 27 Mar 2023 Phase-I clinical trials in Non-small cell lung cancer (Metastatic disease, Inoperable/Unresectable, Late-stage disease) in China (PO) (NCT06050980)
  • 10 Jan 2023 Preclinical trials in Non-small cell lung cancer in China (PO) prior to January 2023

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top